imiquimod has been researched along with monobenzone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Bos, JD; Filippov, DV; Konijnenberg, D; Luiten, RM; Meeuwenoord, NJ; Melief, CJ; Picavet, DI; Tjin, EP; van den Boorn, JG; van der Veen, JP | 1 |
Eby, JM; Hariharan, V; Hernandez, C; Le Poole, IC; Luiten, RM; Webb, KC | 1 |
Boniface, K; Ezzedine, K; Seneschal, J; Taieb, A | 1 |
Grimes, PE; Nashawati, R | 1 |
2 review(s) available for imiquimod and monobenzone
Article | Year |
---|---|
Accelerating bleaching in vitiligo: balancing benefits versus risks.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Humans; Hydroquinones; Imiquimod; Melanocytes; Risk Assessment; Skin Lightening Preparations; Vitiligo | 2014 |
Depigmentation Therapies for Vitiligo.
Topics: Adjuvants, Immunologic; Aminoquinolines; Anisoles; Body Surface Area; Cryotherapy; Cyclopropanes; Humans; Hydroquinones; Imatinib Mesylate; Imiquimod; Low-Level Light Therapy; Patient Selection; Phenol; Protein Kinase Inhibitors; Severity of Illness Index; Skin Lightening Preparations; Vitiligo | 2017 |
3 other study(ies) available for imiquimod and monobenzone
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; CD8-Positive T-Lymphocytes; Cell Proliferation; Dinucleoside Phosphates; Hydroquinones; Imiquimod; Immunoglobulin G; Immunotherapy; Injections, Subcutaneous; Killer Cells, Natural; Leukocyte Count; Lymphocyte Activation; Lymphocyte Depletion; Melanoma; Mice; Mice, Inbred C57BL; Pigmentation; Skin Neoplasms | 2010 |
Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.
Topics: Aminoquinolines; Apoptosis; Chemotherapy, Adjuvant; Drug Therapy, Combination; HSP70 Heat-Shock Proteins; Humans; Hydroquinones; Imiquimod; Immunotherapy; Melanocytes; Oligodeoxyribonucleotides; Skin Lightening Preparations; Toll-Like Receptors; Treatment Outcome; Vitiligo | 2014 |